Harvest One Cannabis inks validation testing agreement with BLOCKStrain Technology

Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) announced Thursday that it has inked a validation testing agreement with BLOCKStrain Technology (CVE:DNAX) to collect and register its cannabis plant DNA and strains.

Harvest One will incorporate BLOCKStrain’s cannabis strain authenticity and tracking platform, known as the Master Genome Strain and Clone Registration Program, into its sales program. 

As a result, Harvest One said, it will be able to confirm its medical cannabis strains are labeled, providing consumers with increased transparency and confidence about its products. 

READ: Harvest One launches Satipharm reformulated CBD capsules in Europe

“BLOCKStrain’s technology is intended to enable us to guarantee that our strain origins and content are exactly as labeled, providing medical consumers with a level of certainty they could not expect with similar, unverified products,” CEO Grant Froese of Harvest One said in a statement. “This increased level of quality control is in keeping with our mission to build a global house of brands, providing lifestyle and wellness health products to consumers and patients in regulated markets.”

Harvest One is a global cannabis company that develops and provides lifestyle and wellness products to consumers and patients in regulated markets around the world. 

According to the statement, 30 Harvest One products will initially carry BLOCKStrain’s Seal of Authenticity, guaranteeing their origin and providing quality assurance, upon completion of the collection and registration of its strains. 

“This agreement with Harvest One is a testament to the growing traction of our proprietary genome-to-sale software, which we expect to increase as more companies recognize the inherent and significant value in protecting the genetics and IP of their various strains,” BLOCKStrain CEO Robert Galarza said. “We believe our unique technology will enable Harvest One to guarantee its strains and provide consumers with unparalleled assuredness about the products they purchase. This is of particular importance for medical cannabis when patients with specific conditions are relying on products to be of consistent quality and provide consistent results.”

BLOCKStrain’s team collects plant data and performs genomic sequencing in batches that are registered in a blockchain-enabled database for intellectual property protection and strain validation.

Contact Katie Lewis at [email protected]

Follow her on Twitter: @kelewis

Story by ProactiveInvestors